Lyra Therapeutics, Inc. (LYRA)

NASDAQ: LYRA · Real-Time Price · USD

6.47

+0.11 (1.73%)

At close: Sep 26, 2025, 4:00 PM EDT

6.60

+0.13 (2.01%)

After-hours: Sep 26, 2025, 5:43 PM EDT

Lyra Therapeutics Stock Forecast

Stock Price Forecast

The 1 analyst with a 12-month price forecast for Lyra Therapeutics stock has a target of 16, which predicts a 147.30% increase from the current stock price of 6.47.

Price Target: $16.00 (+147.30%)

Analyst Consensus: Hold

Target	Low	Average	Median	High
Price	$16	$16	$16	$16
Change	+147.30%	+147.30%	+147.30%	+147.30%

* Price targets were last updated on Aug 14, 2025.

Analyst Ratings

According to 1 stock analyst, the rating for Lyra Therapeutics is "Hold". This means that the analyst believes this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating	Apr '25	May '25	Jun '25	Jul '25	Aug '25	Sep '25
Strong Buy	1	1	0	0	0	0
Buy	1	1	1	1	1	0
Hold	3	3	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	5	5	2	2	2	1

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Matthew Caufield HC Wainwright & Co.	HC Wainwright & Co.	Hold Reiterates $16	Hold	Reiterates	$16	+147.30%	Aug 14, 2025
Matthew Caufield HC Wainwright & Co.	HC Wainwright & Co.	Hold Maintains $2 → $16	Hold	Maintains	$2 → $16	+147.30%	Jun 10, 2025
Matthew Caufield HC Wainwright & Co.	HC Wainwright & Co.	Hold Reiterates $100	Hold	Reiterates	$100	+1,445.60%	Mar 14, 2025
Louise Chen Cantor Fitzgerald	Cantor Fitzgerald	Buy Reiterates n/a	Buy	Reiterates	n/a	n/a	Aug 15, 2024
Matthew Caufield HC Wainwright & Co.	HC Wainwright & Co.	Hold Reiterates $100	Hold	Reiterates	$100	+1,445.60%	Aug 15, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

774.69K

from 1.53M

-49.50%

from 1.53M

Revenue Next Year

1.73M

from 774.69K

123.83%

from 774.69K

EPS This Year

-19.69

from -71.75

EPS Next Year

-9.79

from -19.69

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	-	285.00K	1.36M	1.56M	1.53M	774.69K	1.73M
Revenue Growth	-	-	378.25%	14.31%	-1.54%	-49.50%	123.83%
EPS	-129.46	-167.54	-91.41	-62.93	-71.75	-19.69	-9.79
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	6	5

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026
High	1.6M	4.2M
Avg	774,690	1.7M
Low	392,000	392,000

Revenue Growth

Revenue Growth	2025	2026
High	2.7%	442.2%
Avg	-49.5%	123.8%
Low	-74.4%	-49.4%

EPS Forecast

EPS	2025	2026
High	-11.82	-6.57
Avg	-19.69	-9.79
Low	-25.15	-15.19

EPS Growth

EPS Growth	2025	2026
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.